Figure 5.
The combination of LCL161 + GEM/CIS prevents the emergence of drug-resistant cells. (A–D) The emergence of multidrug-resistant TFK1 and KKU213C cells under various drug treatments. TFK1 and KKU213C cells were treated with GEM/CIS, LCL161, or LCL161 + GEM/CIS for 4 weeks, 8 weeks, or 10 weeks. Emerging colonies were stained with crystal violet and imaged. The number of emerging multidrug-resistant clones in 96-well plates are shown in images B–D. (E, F) The effectiveness of triplet combination and sequential regimen is compared in TFK1R and KKU213R cells. Multidrug-resistant cells were stained with crystal violet and imaged every 5 days. (G, H) The effectiveness of the triplet therapy in TFK1, TFK1R, KKU213C, and KKU213CR cells with and without drug holiday. Cells were treated with LCL161, GEM/CIS, or LCL161 + GEM/CIS and stained with crystal violet at the indicated time points.